Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthma.
about
Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and childrenIntermittent versus daily inhaled corticosteroids for persistent asthma in children and adultsIntermittent versus daily inhaled corticosteroids for persistent asthma in children and adultsAsthma: clinical expression and molecular mechanismsThe use of inhaled corticosteroids in pediatric asthma: updateChildhood asthma: diagnosis and treatmentThe Asthma Control Questionnaire as a clinical trial endpoint: past experience and recommendations for future useBreaking new ground: challenging existing asthma guidelinesPersonal and ambient air pollution is associated with increased exhaled nitric oxide in children with asthmaMonitoring asthma control using claims data and patient-reported outcomes measuresThe Saudi Initiative for Asthma.Effectiveness of montelukast administered as monotherapy or in combination with inhaled corticosteroid in pediatric patients with uncontrolled asthma: a prospective cohort studyLessons learned from variation in response to therapy in clinical trials.Urinary leukotriene E4/exhaled nitric oxide ratio and montelukast response in childhood asthma.In utero smoke exposure and impaired response to inhaled corticosteroids in children with asthma.Asthma and other recurrent wheezing disorders in children (chronic)Clinical predictors and outcomes of consistent bronchodilator response in the childhood asthma management program.Partner randomized controlled trial: study protocol and coaching intervention.Tiotropium bromide step-up therapy for adults with uncontrolled asthmaThe expert network and electronic portal for children with respiratory and allergic symptoms: rationale and design.Pediatric asthma: guidelines-based care, omalizumab, and other potential biologic agents.Impulse oscillometry versus spirometry in a long-term study of controller therapy for pediatric asthma.Scientific respiratory symposium, paris june 2010Biomarker-based asthma phenotypes of corticosteroid response.Prolonged Treatment with Inhaled Corticosteroids does not Normalize High Activity of Matrix Metalloproteinase-9 in Exhaled Breath Condensates of Children with AsthmaMarkers of Differential Response to Inhaled Corticosteroid Treatment Among Children with Mild Persistent AsthmaClinical and economic outcomes associated with low-dose fluticasone propionate versus montelukast in children with asthma aged 4 to 11 years.Lung function and biomarkers of airway inflammation during and after hospitalization for acute exacerbations of childhood asthma associated with viral respiratory symptomsMontelukast versus inhaled corticosteroids in the management of pediatric mild persistent asthmaThe Saudi initiative for asthma - 2012 update: Guidelines for the diagnosis and management of asthma in adults and childrenThe Saudi Initiative for Asthma - 2016 update: Guidelines for the diagnosis and management of asthma in adults and children.Guideline-defining asthma clinical trials of the National Heart, Lung, and Blood Institute's Asthma Clinical Research Network and Childhood Asthma Research and Education Network.Targeted interventions for difficult-to-treat asthma.Assessment of airway inflammation with exhaled NO measurement.Update on montelukast and its role in the treatment of asthma, allergic rhinitis and exercise-induced bronchoconstriction.Exhaled nitric oxide in children with asthma and sinusitis.Immunoglobulin E blockade in the treatment of asthma.Phenotypic predictors of long-term response to inhaled corticosteroid and leukotriene modifier therapies in pediatric asthmaEffect of fluticasone 250 microg/salmeterol 50 microg and montelukast on exhaled nitric oxide in asthmatic patients.Predictors of response to tiotropium versus salmeterol in asthmatic adults.
P2860
Q24197682-8F650EAE-71C4-48E9-BE75-610ADD4D731FQ24200804-2EDB0BA7-7752-460D-9B32-046BA4915F4AQ24202489-0DB6E456-72DE-42FC-8C8E-885A19636E01Q24597331-06AE4911-258A-49C8-9BAA-EE8DCAD7ABF8Q26739763-2E70C4CA-922B-4C2F-9487-6652D1241458Q26863351-E5910168-BB11-4E06-A38D-C8407560E59CQ27025354-DF1C7457-BF10-4DC4-BD61-89FC301C19DEQ28211652-38C8D9F7-696B-4610-AAB9-A642101295A1Q28766354-D5FB3EA3-2A24-4057-9CA7-C647345A2E8DQ33502728-8C76816E-0472-4E94-AF7A-0854867A2DE1Q33568644-FF4D7B02-FF2D-4ACA-88C0-EF56AD19983CQ33755127-6D3DE707-4E0F-4EF5-AF34-1BDFEFE48481Q33999050-EF53B4D7-4595-4F1E-BE84-488587C8E422Q34112531-CD79D01E-0500-49BF-864B-01C992A22F24Q34120964-56FEF802-1F58-430A-B8FE-B503E6CC23C4Q34150855-CECE8A5C-C098-495A-A2CE-B9E305FF0DB5Q34165210-889C1F55-49AD-4328-A1FD-93C2937B41F6Q34216961-3AD9E15B-5F78-48C7-BB4C-8113BD65073CQ34444935-F7599484-2B80-42E0-B40F-91A2471AE426Q34549851-4441A049-378B-469F-9923-E68815B6FC1DQ34625206-F8568480-463C-48A6-A124-FA1B35A8796EQ34923650-E9FE96F3-058E-4568-A341-1AFF47289F66Q35117833-860F0FF9-C946-4E5B-8E52-D28F32515F5FQ35305384-5244434A-26BC-4363-8226-81F38D493ABDQ35598652-249752F2-46A5-480A-BEE6-72F39FD8397FQ35846993-D76874F9-B20D-429F-B2E6-5A762EE5E9CFQ36081869-133C09F7-F658-449F-A8CC-B95BE335F806Q36198171-DFB1B11B-1AF4-47FD-AD22-8498D323BB87Q36217677-435E017A-7CA2-4E0C-A43C-2AD84CCBE35DQ36422663-AABB1B0D-40FC-428E-82A2-F2666A9F1F45Q36566081-E62FE6AE-88EE-4B33-90CC-FDEB7F6DB949Q36671746-FFA2D664-9DBD-4664-B8BB-BDD1CE01B008Q36675485-8D99F1DA-A3D6-466F-A32C-BCB906D5756FQ36765980-4A24261E-B9F0-4753-8B40-0763B4CA83EDQ36916936-6B169E44-C79F-488B-BF9C-8D6C10C8CEDEQ36927682-30E38F7C-34F0-4442-A953-76548B28E458Q36951998-1344F9AA-CDDA-46AE-B9DA-B306A129E274Q37142937-32D3B894-9C72-45F3-B721-6F28454643B4Q37181742-7C51C7D5-CD26-4936-8076-F99C00F9BD7CQ37303840-17762B3B-35AC-42D7-8C51-C3ED00A1CEB9
P2860
Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthma.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Response profiles to fluticaso ...... e persistent childhood asthma.
@en
Response profiles to fluticaso ...... e persistent childhood asthma.
@nl
type
label
Response profiles to fluticaso ...... e persistent childhood asthma.
@en
Response profiles to fluticaso ...... e persistent childhood asthma.
@nl
prefLabel
Response profiles to fluticaso ...... e persistent childhood asthma.
@en
Response profiles to fluticaso ...... e persistent childhood asthma.
@nl
P2093
P50
P1476
Response profiles to fluticaso ...... e persistent childhood asthma.
@en
P2093
Brenda R Phillips
Childhood Asthma Research and ...... art, Lung, and Blood Institute
Christine A Sorkness
Fernando D Martinez
Gary Larsen
Gordon R Bloomberg
Gregory Heldt
Joseph D Spahn
Lynn M Taussig
Mark H Moss
P356
10.1016/J.JACI.2005.10.012
P407
P577
2006-01-01T00:00:00Z